Creatine Research Today is a free monthly online journal that collates and summarizes the latest research about Creatine, including details on supplements, side-effects, benefits, dangers, muscle growth.

Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.

Bender A, Koch W, Elstner M, Schombacher Y, Bender J, Moeschl M, Gekeler F, Müller-Myhsok B, Gasser T, Tatsch K, Klopstock T

Department of Neurology, Klinikum Grosshadern, Klinikum Grosshadern, University of Munich, Germany.

Mitochondrial dysfunction plays a major role in the pathogenesis of Parkinson disease (PD). Creatine (Cr) is an ergogenic compound that exerts neuroprotective effects in animal models of PD. We conducted a 2-year placebo-controlled randomized clinical trial on the effect of Cr in 60 patients with PD. Cr improved patient mood and led to a smaller dose increase of dopaminergic therapy but had no effect on overall Unified Parkinson's Disease Rating Scale scores or dopamine transporter SPECT.

Published 10 October 2006 in Neurology, 67(7): 1262-4.
Full-text of this article is available online (may require subscription).

© 2004-2008 Creatine Research Today. All Rights Reserved.